(1) The product passes quality control evaluation from a designated independent quality assurance auditor. |
(1) Initial testing pre-scale up, repeat if manufacturing process changes; periodic spot-checks |
(1) National authority review, local bylaw mandate documentation |
(1) Knowledgeable and unprejudicial national, and independent assessors. |
(2) Staff trained on product use and are able to demonstrate knowledge of correct use of MHM2 Innovative Product. |
(2) Beginning of scale up; repeat at interim to identify if retraining needed |
(2) Training logs; assessment forms of trained personnel |
(2) Accurate count of all trained; accurate questions used to demonstrate correct knowledge |
(1) Number of units of product manufactured per month; Number of units distributed by location [country/area] or vendor type. |
(1) Monthly or quarterly; summarize annually. |
(1) Company manufacturing, inventory, and distribution logs; vendor stock-check |
(1) Quality of auditing (spot-checks) of manufacturing and distribution logs that ensure quality of reporting |
(1) Number and type of individuals trained on debunking MHM myths and taboos |
(1) Beginning of program; repeat assessment at interim to identify if retraining needed |
(1) Training logs; periodic assessment of trained cadre |
(1) Accurate count of all trained; representative sampling of trained; accurate questions used to demonstrate correct knowledge around local myths and taboos |
(1) Number of beneficiaries’ and groups reporting: Innovative MHM Product is available and accessible to them, by area |
(1) Annual measure showing permeation. |
(1) Quantitative: Survey of beneficiaries and caregivers documenting MHM product is available and accessible to them in their community; vendors. |
(1) Representative of beneficiaries; stratified by target populations, girls, women, in-out of school, occupation, rural/urban, hard to reach. |